[1]
“Exploring the Impact of 12-week Direct Acting Antiviral Therapy on Laboratory Parameters in HCV Patients: A Comparative Study”, mfm, vol. 35, no. 2, Feb. 2024, Accessed: Dec. 26, 2025. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/45